Oprah Winfrey Opens Up About Weight Loss Drugs and Overcoming Shame

Oprah Winfrey discusses the impact of being shamed in the tabloids for her weight and the difference between mindset and willpower in personal weight loss journeys. As part of "The State of Weight" panel conversation, Winfrey aims to reframe and destigmatize conversations surrounding obesity and explore the safety and efficacy of weight loss drugs like Ozempic. The series will feature discussions with WeightWatchers CEO Sima Sistani, obesity specialists, and a psychologist to address weight issues affecting 2 billion adults globally. Semaglutide, the active ingredient in Ozempic, works by reducing hunger and increasing fullness, helping individuals feel satisfied with smaller meals and decreasing the need for snacks.